Domů › Obesity › Florida › Orlando
Klinické studie Obesity v Orlando, FL
31 studií pro Obesity hledá účastníky v lokalitách v Orlando a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Probíhá náborFáze 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Probíhá nábor
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Probíhá náborFáze 1Vítáni zdraví dobrovolníci
- Kailera Clinical Site, Orlando
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Probíhá náborFáze 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · Vzdálenost 6 mi
- Omega Research Orlando, Altamonte Springs · Vzdálenost 9 mi
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Probíhá náborFáze 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Probíhá náborFáze 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · Vzdálenost 5 mi
- K2 Medical Research Maitland LLC, Main Office, Maitland · Vzdálenost 6 mi
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Probíhá náborFáze 2
- Clinical Neuroscience Solutions, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Probíhá náborFáze 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Probíhá náborFáze 3
- Florida Inst For Clin Res LLC, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Probíhá náborFáze 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Probíhá náborFáze 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Probíhá náborFáze 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Probíhá náborFáze 3
- Clinical Neuroscience Solution, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Probíhá náborFáze 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · Vzdálenost 5 mi
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Probíhá náborFáze 3
- Research Site, Ocoee · Vzdálenost 10 mi
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Probíhá náborFáze 3
- West Orange Endocrinology, Ocoee · Vzdálenost 10 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Probíhá náborFáze 3
- Conquest Research, Winter Park · Vzdálenost 5 mi
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Probíhá náborFáze 2
- Charter Research - Winter Park, Orlando
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Probíhá náborFáze 3
- AURORA-1 Clinical Site, Winter Park · Vzdálenost 5 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Probíhá náborFáze 3
- AURORA-2 Clinical Site, Winter Park · Vzdálenost 5 mi
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Probíhá náborFáze 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · Vzdálenost 5 mi
- a dalších 1
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Probíhá nábor
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Probíhá náborFáze 3Vítáni zdraví dobrovolníci
- ACCOMPLISH-2 Research Site, Ocoee · Vzdálenost 10 mi
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Probíhá náborFáze 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Probíhá náborFáze 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Probíhá náborFáze 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Probíhá náborFáze 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · Vzdálenost 5 mi
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Probíhá náborFáze 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Probíhá náborFáze 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · Vzdálenost 5 mi
- K2 Medical Research, Maitland · Vzdálenost 6 mi
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Probíhá náborFáze 3
- ACCOMPLISH-1 Research Site, Ocoee · Vzdálenost 10 mi
Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
Probíhá náborVítáni zdraví dobrovolníci
- AdventHealth Translational Research Institute, Orlando
Studie Obesity v jiných městech
- Houston, TX43 studií
- Chicago, IL41 studií
- New York City, NY40 studií
- San Antonio, TX40 studií
- Washington, DC33 studií
- Dallas, TX30 studií
- Boston, MA28 studií
- Las Vegas, NV27 studií
- Miami, FL27 studií
- Baltimore, MD25 studií
- Jacksonville, FL25 studií
- St. Louis, MO25 studií
Další studie v Orlando
- Nemalobuněčný plicní karcinom44 studií
- Metastatický karcinom29 studií
- Nadváha27 studií
- Alzheimerova choroba25 studií
- Diabetes mellitus 2. typu24 studií
- Rakovina (všechny typy)24 studií
- Rakovina prsu23 studií
- Rakovina vaječníků22 studií
- Ulcerózní kolitida22 studií
- Rakovina plic21 studií
- Kolorektální karcinom19 studií
- Depresivní epizoda19 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.